» Articles » PMID: 24675895

Helminth-associated Systemic Immune Activation and HIV Co-receptor Expression: Response to Albendazole/praziquantel Treatment

Abstract

Background: It has been hypothesized that helminth infections increase HIV susceptibility by enhancing systemic immune activation and hence contribute to elevated HIV-1 transmission in sub-Saharan Africa.

Objective: To study systemic immune activation and HIV-1 co-receptor expression in relation to different helminth infections and in response to helminth treatment.

Methods: HIV-negative adults with (n = 189) or without (n = 57) different helminth infections, as diagnosed by Kato-Katz, were enrolled in Mbeya, Tanzania. Blinded to helminth infection status, T cell differentiation (CD45RO, CD27), activation (HLA-DR, CD38) and CCR5 expression was determined at baseline and 3 months after Albendazole/Praziquantel treatment. Plasma cytokine levels were compared using a cytometric bead array.

Results: Trichuris and Ascaris infections were linked to increased frequencies of "activated" CD4 and/or CD8 T cells (p<0.05), whereas Hookworm infection was associated with a trend towards decreased HLA-DR+ CD8 T cell frequencies (p = 0.222). In Trichuris infected subjects, there was a linear correlation between HLA-DR+ CD4 T cell frequencies and the cytokines IL-1β and IL-10 (p<0.05). Helminth treatment with Albendazole and Praziquantel significantly decreased eosinophilia for S. mansoni and Hookworm infections (p<0.005) but not for Trichuris infection and only moderately modulated T cell activation. CCR5 surface density on memory CD4 T cells was increased by 1.2-fold during Trichuris infection (p-value: 0.053) and reduced after treatment (p = 0.003).

Conclusions: Increased expression of T cell activation markers was associated with Trichuris and Ascaris infections with relatively little effect of helminth treatment.

Citing Articles

Anti-HIV Activity and Immunomodulatory Properties of Fractionated Crude Extracts of .

Kubheka M, Ndlovu S, Mkhwanazi N Microorganisms. 2024; 12(6).

PMID: 38930532 PMC: 11205553. DOI: 10.3390/microorganisms12061150.


High frequency of HIV precursor-target-specific B cells in sub-Saharan populations.

Matassoli F, Cagigi A, Shen C, Henry A, Johnston T, Schramm C Cell Rep. 2023; 42(12):113450.

PMID: 38019653 PMC: 10886445. DOI: 10.1016/j.celrep.2023.113450.


Cytokine Gene Expression Profiles during HIV and Helminth Coinfection in Underprivileged Peri-Urban South African Adults.

Mpaka-Mbatha M, Naidoo P, Bhengu K, Islam M, Singh R, Nembe-Mafa N Diagnostics (Basel). 2023; 13(15).

PMID: 37568838 PMC: 10417227. DOI: 10.3390/diagnostics13152475.


Gut Helminth Infection-Induced Immunotolerance and Consequences for Human Papillomavirus Persistence.

Clark E, Gilman R, Chiao E, Gravitt P Am J Trop Med Hyg. 2021; 105(3):573-583.

PMID: 34280146 PMC: 8592347. DOI: 10.4269/ajtmh.21-0191.


Chronic Immune Activation and CD4 T Cell Lymphopenia in Healthy African Individuals: Perspectives for SARS-CoV-2 Vaccine Efficacy.

Wolday D, Ndungu F, Gomez-Perez G, Wit T Front Immunol. 2021; 12:693269.

PMID: 34220854 PMC: 8249933. DOI: 10.3389/fimmu.2021.693269.


References
1.
Kassu A, Tsegaye A, Wolday D, Petros B, Aklilu M, Sanders E . Role of incidental and/or cured intestinal parasitic infections on profile of CD4+ and CD8+ T cell subsets and activation status in HIV-1 infected and uninfected adult Ethiopians. Clin Exp Immunol. 2003; 132(1):113-9. PMC: 1808681. DOI: 10.1046/j.1365-2249.2003.02106.x. View

2.
Zack J, Arrigo S, Weitsman S, Go A, Haislip A, Chen I . HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell. 1990; 61(2):213-22. DOI: 10.1016/0092-8674(90)90802-l. View

3.
Koning F, Otto S, Hazenberg M, Dekker L, Prins M, Miedema F . Low-level CD4+ T cell activation is associated with low susceptibility to HIV-1 infection. J Immunol. 2005; 175(9):6117-22. DOI: 10.4049/jimmunol.175.9.6117. View

4.
Querec T, Akondy R, Lee E, Cao W, Nakaya H, Teuwen D . Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol. 2008; 10(1):116-125. PMC: 4049462. DOI: 10.1038/ni.1688. View

5.
Kalinkovich A, Weisman Z, Greenberg Z, Nahmias J, Shapiro M, Panet A . Increased susceptibility to HIV-1 infection of peripheral blood mononuclear cells from chronically immune-activated individuals. AIDS. 1998; 12(13):1731-3. View